Noble Parkway Medical Clinic Professional Corporation | |
4808 85th Ave North Suite 300 Brooklyn Park MN 55443 | |
(763) 496-1562 | |
(763) 657-0581 |
Full Name | Noble Parkway Medical Clinic Professional Corporation |
---|---|
Speciality | Clinic/Center |
Location | 4808 85th Ave North, Brooklyn Park, Minnesota |
Authorized Official Name and Position | Tajudeen O Fawole (CEO) |
Authorized Official Contact | 7634961562 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Noble Parkway Medical Clinic Professional Corporation 4808 85th Ave North Suite 300 Brooklyn Park MN 55443 Ph: (763) 496-1562 | Noble Parkway Medical Clinic Professional Corporation 4808 85th Ave North Suite 300 Brooklyn Park MN 55443 Ph: (763) 496-1562 |
NPI Number | 1043556517 |
---|---|
Provider Enumeration Date | 01/02/2013 |
Last Update Date | 05/16/2013 |
Medicare PECOS PAC ID | 8921245689 |
---|---|
Medicare Enrollment ID | O20130516000538 |
News Archive
Could a one-a-day pill be the answer for women with stress urinary incontinence - a condition resulting in leakage with coughing, sneezing and laughing?
A reduction in prescription drug coverage under last year's state budget cuts means 292,000 New Yorkers will now be paying more at the pharmacy.
United Therapeutics Corporation announced today that the United States Food and Drug Administration has approved Orenitram (treprostinil) Extended-Release Tablets for the treatment of pulmonary arterial hypertension in WHO Group I patients to improve exercise capacity.
The U.S. Food and Drug Administration today permitted marketing of the first blood test to evaluate mild traumatic brain injury (mTBI), commonly referred to as concussion, in adults.
Paragonix Technologies, Inc. today announced that the European Society for Organ Transplantation accepted for presentation an abstract describing the performance of the Sherpa Pak™ Cardiac Transport System during the upcoming 16th Congress of the European Society for Organ Transplantation to be held in Vienna, Austria from the 8th - 11th September 2013.
› Verified 3 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1043556517 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
261QP2300X | Clinic/center - Primary Care | (* (Not Available)) | Primary |
Provider Name | Tajudeen O Fawole |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1801991005 PECOS PAC ID: 8729017082 Enrollment ID: I20061023000043 |
News Archive
Could a one-a-day pill be the answer for women with stress urinary incontinence - a condition resulting in leakage with coughing, sneezing and laughing?
A reduction in prescription drug coverage under last year's state budget cuts means 292,000 New Yorkers will now be paying more at the pharmacy.
United Therapeutics Corporation announced today that the United States Food and Drug Administration has approved Orenitram (treprostinil) Extended-Release Tablets for the treatment of pulmonary arterial hypertension in WHO Group I patients to improve exercise capacity.
The U.S. Food and Drug Administration today permitted marketing of the first blood test to evaluate mild traumatic brain injury (mTBI), commonly referred to as concussion, in adults.
Paragonix Technologies, Inc. today announced that the European Society for Organ Transplantation accepted for presentation an abstract describing the performance of the Sherpa Pak™ Cardiac Transport System during the upcoming 16th Congress of the European Society for Organ Transplantation to be held in Vienna, Austria from the 8th - 11th September 2013.
› Verified 3 days ago
Provider Name | Abejide O Fawole |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1497939565 PECOS PAC ID: 8022192095 Enrollment ID: I20080303000815 |
News Archive
Could a one-a-day pill be the answer for women with stress urinary incontinence - a condition resulting in leakage with coughing, sneezing and laughing?
A reduction in prescription drug coverage under last year's state budget cuts means 292,000 New Yorkers will now be paying more at the pharmacy.
United Therapeutics Corporation announced today that the United States Food and Drug Administration has approved Orenitram (treprostinil) Extended-Release Tablets for the treatment of pulmonary arterial hypertension in WHO Group I patients to improve exercise capacity.
The U.S. Food and Drug Administration today permitted marketing of the first blood test to evaluate mild traumatic brain injury (mTBI), commonly referred to as concussion, in adults.
Paragonix Technologies, Inc. today announced that the European Society for Organ Transplantation accepted for presentation an abstract describing the performance of the Sherpa Pak™ Cardiac Transport System during the upcoming 16th Congress of the European Society for Organ Transplantation to be held in Vienna, Austria from the 8th - 11th September 2013.
› Verified 3 days ago
Provider Name | Olitha J Fofana |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1013301407 PECOS PAC ID: 1254643349 Enrollment ID: I20150701002832 |
News Archive
Could a one-a-day pill be the answer for women with stress urinary incontinence - a condition resulting in leakage with coughing, sneezing and laughing?
A reduction in prescription drug coverage under last year's state budget cuts means 292,000 New Yorkers will now be paying more at the pharmacy.
United Therapeutics Corporation announced today that the United States Food and Drug Administration has approved Orenitram (treprostinil) Extended-Release Tablets for the treatment of pulmonary arterial hypertension in WHO Group I patients to improve exercise capacity.
The U.S. Food and Drug Administration today permitted marketing of the first blood test to evaluate mild traumatic brain injury (mTBI), commonly referred to as concussion, in adults.
Paragonix Technologies, Inc. today announced that the European Society for Organ Transplantation accepted for presentation an abstract describing the performance of the Sherpa Pak™ Cardiac Transport System during the upcoming 16th Congress of the European Society for Organ Transplantation to be held in Vienna, Austria from the 8th - 11th September 2013.
› Verified 3 days ago
Provider Name | Nkeiruka Sylvia Anyiam |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1427425750 PECOS PAC ID: 4486959236 Enrollment ID: I20160216002668 |
News Archive
Could a one-a-day pill be the answer for women with stress urinary incontinence - a condition resulting in leakage with coughing, sneezing and laughing?
A reduction in prescription drug coverage under last year's state budget cuts means 292,000 New Yorkers will now be paying more at the pharmacy.
United Therapeutics Corporation announced today that the United States Food and Drug Administration has approved Orenitram (treprostinil) Extended-Release Tablets for the treatment of pulmonary arterial hypertension in WHO Group I patients to improve exercise capacity.
The U.S. Food and Drug Administration today permitted marketing of the first blood test to evaluate mild traumatic brain injury (mTBI), commonly referred to as concussion, in adults.
Paragonix Technologies, Inc. today announced that the European Society for Organ Transplantation accepted for presentation an abstract describing the performance of the Sherpa Pak™ Cardiac Transport System during the upcoming 16th Congress of the European Society for Organ Transplantation to be held in Vienna, Austria from the 8th - 11th September 2013.
› Verified 3 days ago
Provider Name | Alade L Hamza |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1144862996 PECOS PAC ID: 6305251471 Enrollment ID: I20210223001758 |
News Archive
Could a one-a-day pill be the answer for women with stress urinary incontinence - a condition resulting in leakage with coughing, sneezing and laughing?
A reduction in prescription drug coverage under last year's state budget cuts means 292,000 New Yorkers will now be paying more at the pharmacy.
United Therapeutics Corporation announced today that the United States Food and Drug Administration has approved Orenitram (treprostinil) Extended-Release Tablets for the treatment of pulmonary arterial hypertension in WHO Group I patients to improve exercise capacity.
The U.S. Food and Drug Administration today permitted marketing of the first blood test to evaluate mild traumatic brain injury (mTBI), commonly referred to as concussion, in adults.
Paragonix Technologies, Inc. today announced that the European Society for Organ Transplantation accepted for presentation an abstract describing the performance of the Sherpa Pak™ Cardiac Transport System during the upcoming 16th Congress of the European Society for Organ Transplantation to be held in Vienna, Austria from the 8th - 11th September 2013.
› Verified 3 days ago
News Archive
Could a one-a-day pill be the answer for women with stress urinary incontinence - a condition resulting in leakage with coughing, sneezing and laughing?
A reduction in prescription drug coverage under last year's state budget cuts means 292,000 New Yorkers will now be paying more at the pharmacy.
United Therapeutics Corporation announced today that the United States Food and Drug Administration has approved Orenitram (treprostinil) Extended-Release Tablets for the treatment of pulmonary arterial hypertension in WHO Group I patients to improve exercise capacity.
The U.S. Food and Drug Administration today permitted marketing of the first blood test to evaluate mild traumatic brain injury (mTBI), commonly referred to as concussion, in adults.
Paragonix Technologies, Inc. today announced that the European Society for Organ Transplantation accepted for presentation an abstract describing the performance of the Sherpa Pak™ Cardiac Transport System during the upcoming 16th Congress of the European Society for Organ Transplantation to be held in Vienna, Austria from the 8th - 11th September 2013.
› Verified 3 days ago
Uplifted Community Services Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3340 Brookdale Dr N, Brooklyn Park, MN 55443 Phone: 763-280-3236 | |
Voyage Healthcare Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 9201 W Broadway Ave Ste 601, Brooklyn Park, MN 55445 Phone: 763-587-7900 Fax: 763-587-7066 | |
Cpmg-brooklyn Park Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 10000 Zane Ave N, Brooklyn Park, MN 55443 Phone: 763-572-5710 Fax: 763-569-6200 | |
Assured Health Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 8421 W Broadway Ave, Brooklyn Park, MN 55445 Phone: 952-212-0911 Fax: 651-300-1956 | |
Zenith Medical Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 6800 78th Ave N, Suite 110, Brooklyn Park, MN 55445 Phone: 763-503-1122 Fax: 763-503-1127 | |
Midpoint Medical Clinic Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 7240 Brooklyn Blvd, Suite 200, Brooklyn Park, MN 55429 Phone: 763-566-2313 |